Welcome to DIAN
On Tuesday September 10, Francisco Lopera died of cancer at his home in Medellin, Colombia. He was 73, and only just beginning to see his life’s work come to fruition.
Thank you to all the participants in the 2024 Conference in Philadelphia. Our highlight this year …..
MEMO DATE: 15 April 2024 TO: DIAN-TU-001 Gantenerumab Open Label Extension Participants FROM: Dr. Randall Bateman, Director, Knight Family DIAN-TU and Dr. Eric McDade, Associate Director, Knight Family DIAN-TU RE: DIAN-TU-003 Amyloid Removal Trial As previously announced by the DIAN-TU on 18 December 2023 and the Alzheimer’s Association on 09 April 2024, the Knight Family Dominantly Inherited Alzheimer […]
The statement below is an update to the 20 December 2022 announcement by the Knight Family Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) regarding the DIAN-TU-002 Primary Prevention Trial. In late 2022, the Knight Family DIAN-TU paused the launch of the DIAN-TU-002 Primary Prevention Trial of gantenerumab due to discontinuation of the drug development program. […]
Webinar with Dr. Eric McDade on May 4, 2024, on the Primary Prevention Trial.
Webinar with Dr. Randall Bateman on May 4, 2024, on the Amyloid Removal Trial (ART) for former participants in the open-label extension trial with gantenerumab.
Question and answer session with Dr. Randall Bateman on December 16, 2023, on the Amyloid Removal Trial (ART) for former participants in the open-label extension trial with gantenerumab.